BLMN vs PFE · P/E 32, rev $2.08B vs P/E 20, rev $62.58B
Bloomin Brands Inc (BLMN) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Bloomin Brands Inc (BLMN) is a restaurants company listed on NASDAQ.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported BLMN revenue for 2026-06-28 was $2.08B. Net income was $87.0M. Revenue was up 95.9% from 2026-03-29 to 2026-06-28. BLMN currently screens at market cap $657.5M and trailing P/E 32.0.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
BLMN currently screens at market cap $657.5M and trailing P/E 32.0. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the BLMN and PFE stock pages for the full models.
Not investment advice.